Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Carr

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|February 17, 2005
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysisJames E Goin, Riad Salem, Brian I Carr, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 17, 2005
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicitiesJames E Goin, Riad Salem, Brian I Carr, et al.
Gastroenterology|October 28, 2004
Yttrium-90 microspheres for the treatment of hepatocellular carcinomaJean Francois H Geschwind, Riad Salem, Brian I Carr, et al.
World Journal of Gastrointestinal Surgery|January 13, 2021
Liver transplant for large hepatocellular carcinoma in Malatya: The role of gamma glutamyl transferase and alpha-fetoprotein, a retrospective cohort studyVolkan Ince, Brian I Carr, Harika Gozukara Bag, et al.
Proteomics|October 3, 2009
Systematic prediction of human membrane receptor interactionsYanjun Qi, Harpreet K Dhiman, Neil Bhola, et al.
Journal of Medicinal Chemistry|July 11, 2006
Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivoPaul J Shami, Joseph E Saavedra, Challice L Bonifant, et al.
Journal of Pain and Symptom Management|May 18, 2010
Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory studyJennifer L Steel, Kevin H Kim, Mary Amanda Dew, et al.
Seminars in Oncology|July 16, 2014
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parametersBrian I Carr, Petr Pancoska, Edoardo G Giannini, et al.
Seminars in Oncology|May 3, 2014
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotypeBrian I Carr, Vito Guerra, Edoardo G Giannini, et al.
Journal of Integrative Oncology|June 6, 2017
A Liver Index and its Relationship to Indices of HCC AggressivenessBrian I Carr, Vito Guerra, Edoardo G Giannini, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Journal of Vascular and Interventional Radiology : JVIR|February 17, 2005
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysisJames E Goin, Riad Salem, Brian I Carr, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 17, 2005
Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicitiesJames E Goin, Riad Salem, Brian I Carr, et al.
Gastroenterology|October 28, 2004
Yttrium-90 microspheres for the treatment of hepatocellular carcinomaJean Francois H Geschwind, Riad Salem, Brian I Carr, et al.
World Journal of Gastrointestinal Surgery|January 13, 2021
Liver transplant for large hepatocellular carcinoma in Malatya: The role of gamma glutamyl transferase and alpha-fetoprotein, a retrospective cohort studyVolkan Ince, Brian I Carr, Harika Gozukara Bag, et al.
Proteomics|October 3, 2009
Systematic prediction of human membrane receptor interactionsYanjun Qi, Harpreet K Dhiman, Neil Bhola, et al.
Journal of Medicinal Chemistry|July 11, 2006
Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivoPaul J Shami, Joseph E Saavedra, Challice L Bonifant, et al.
Journal of Pain and Symptom Management|May 18, 2010
Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory studyJennifer L Steel, Kevin H Kim, Mary Amanda Dew, et al.
Seminars in Oncology|July 16, 2014
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parametersBrian I Carr, Petr Pancoska, Edoardo G Giannini, et al.
Seminars in Oncology|May 3, 2014
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotypeBrian I Carr, Vito Guerra, Edoardo G Giannini, et al.
Journal of Integrative Oncology|June 6, 2017
A Liver Index and its Relationship to Indices of HCC AggressivenessBrian I Carr, Vito Guerra, Edoardo G Giannini, et al.
Pageof 19